In a study investigating the effect of dietary intervention, the newly-diagnosed obese prostate cancer patients were randomized to a CR diet group or a control group and differences in weight loss and insulin-like growth factor (IGF)-binding proterin-3 (IGFBP-3) levels were found in the CR group [72]. This evidence concerns the gene IGF1 and prostate cancer.